GE HealthCare Technologies Inc.

Symbol: GEHC

NASDAQ

82.73

USD

Market price today

  • 24.0286

    P/E Ratio

  • 0.6822

    PEG Ratio

  • 37.76B

    MRK Cap

  • 0.00%

    DIV Yield

GE HealthCare Technologies Inc. (GEHC) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.41%

Operating Profit Margin

0.12%

Net Profit Margin

0.08%

Return on Assets

0.05%

Return on Equity

0.22%

Return on Capital Employed

0.10%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO:Mr. Peter J. Arduini
Full-time employees:51000
City:Chicago
Address:500 West Monroe Street
IPO:2022-12-15
CIK:0001932393

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

General Outlook

When we look at how much money they make before expenses, they keep 0.407% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.124%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.081%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.049% return, is a testament to GE HealthCare Technologies Inc.'s adeptness in optimizing resource deployment. GE HealthCare Technologies Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.218%. Furthermore, the proficiency of GE HealthCare Technologies Inc. in capital utilization is underscored by a remarkable 0.103% return on capital employed.

Stock Prices

GE HealthCare Technologies Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $79.13, while its low point bottomed out at $76.5. This variance in figures offers investors a lucid insight into the roller-coaster ride that is GE HealthCare Technologies Inc.'s stock market.

Liquidity Ratios

Analyzing GEHC liquidity ratios reveals its financial health of the firm. The current ratio of 105.80% gauges short-term asset coverage for liabilities. The quick ratio (74.14%) assesses immediate liquidity, while the cash ratio (28.80%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio105.80%
Quick Ratio74.14%
Cash Ratio28.80%

Profitability Ratios

GEHC profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 11.94% underscores its earnings before tax deductions. The effective tax rate stands at 30.25%, revealing its tax efficiency. The net income per EBT, 67.47%, and the EBT per EBIT, 96.32%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 12.39%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin11.94%
Effective Tax Rate30.25%
Net Income per EBT67.47%
EBT per EBIT96.32%
EBIT per Revenue12.39%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.06, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding74
Days of Inventory Outstanding63
Operating Cycle137.99
Days of Payables Outstanding93
Cash Conversion Cycle45
Receivables Turnover4.85
Payables Turnover3.95
Inventory Turnover5.81
Fixed Asset Turnover7.97
Asset Turnover0.61

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 4.50, and free cash flow per share, 3.65, depict cash generation on a per-share basis. The cash per share value, 5.59, showcases liquidity position. A payout ratio of 0.03 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.11, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share4.50
Free Cash Flow per Share3.65
Cash per Share5.59
Payout Ratio0.03
Operating Cash Flow Sales Ratio0.11
Free Cash Flow to Operating Cash Flow Ratio0.81
Cash Flow Coverage Ratio0.21
Short Term Coverage Ratio1.84
Capital Expenditure Coverage Ratio5.28
Dividend Paid and Capex Coverage Ratio4.77

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 30.02%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.31, we discern the balance between debt and equity financing. The long-term debt to capitalization, 53.58%, and total debt to capitalization, 56.62%, ratios shed light on its capital structure. An interest coverage of 4.44 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio30.02%
Debt Equity Ratio1.31
Long Term Debt to Capitalization53.58%
Total Debt to Capitalization56.62%
Interest Coverage4.44
Cash Flow to Debt Ratio0.21
Company Equity Multiplier4.35

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 42.97, provides a glimpse into top-line earnings distributed across each share. Net income per share, 3.45, reflects the portion of profit attributed to each share. The book value per share, 15.68, represents the net asset value distributed per share, while the tangible book value per share, -15.12, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share42.97
Net Income Per Share3.45
Book Value Per Share15.68
Tangible Book Value Per Share-15.12
Shareholders Equity Per Share15.68
Interest Debt Per Share22.87
Capex Per Share-0.85

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 6.60%, indicates top-line expansion, while the gross profit growth, 10.35%, reveals profitability trends. EBIT growth, -3.45%, and operating income growth, -3.45%, offer insights into operational profitability progression. The net income growth, -18.16%, showcases bottom-line expansion, and the EPS growth, -27.96%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth6.60%
Gross Profit Growth10.35%
EBIT Growth-3.45%
Operating Income Growth-3.45%
Net Income Growth-18.16%
EPS Growth-27.96%
EPS Diluted Growth-28.44%
Weighted Average Shares Growth0.24%
Weighted Average Shares Diluted Growth0.90%
Operating Cash Flow Growth-0.57%
Free Cash Flow Growth-4.94%
10-Year Revenue Growth per Share17.47%
5-Year Revenue Growth per Share17.47%
3-Year Revenue Growth per Share13.84%
10-Year Operating CF Growth per Share5.56%
5-Year Operating CF Growth per Share5.56%
3-Year Operating CF Growth per Share24.46%
10-Year Net Income Growth per Share2.82%
5-Year Net Income Growth per Share2.82%
3-Year Net Income Growth per Share-23.86%
3-Year Shareholders Equity Growth per Share-51.60%
Receivables Growth-1.09%
Inventory Growth-9.05%
Asset Growth17.85%
Book Value per Share Growth-23.95%
Debt Growth19.57%
R&D Expense Growth17.45%
SGA Expenses Growth17.93%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 42,549,600,000, captures the company's total value, considering both debt and equity. Income quality, 1.30, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 43.72%, indicates the value of non-physical assets, and capex to operating cash flow, -18.42%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value42,549,600,000
Income Quality1.30
Research and Development to Revenue6.16%
Intangibles to Total Assets43.72%
Capex to Operating Cash Flow-18.42%
Capex to Revenue-1.98%
Capex to Depreciation-63.44%
Stock-Based Compensation to Revenue0.58%
Graham Number34.86
Return on Tangible Assets8.58%
Graham Net Net-40.61
Working Capital429,000,000
Tangible Asset Value-6,879,000,000
Net Current Asset Value-15,734,000,000
Invested Capital1
Average Receivables4,277,500,000
Average Payables2,945,500,000
Average Inventory2,057,500,000
Days Sales Outstanding79
Days Payables Outstanding92
Days of Inventory On Hand62
ROIC9.82%
ROE0.22%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 5.09, and the price to book ratio, 5.09, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.94, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 22.71, and price to operating cash flows, 18.38, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio5.09
Price to Book Ratio5.09
Price to Sales Ratio1.94
Price Cash Flow Ratio18.38
Price Earnings to Growth Ratio0.68
Enterprise Value Multiple9.24
Price Fair Value5.09
Price to Operating Cash Flow Ratio18.38
Price to Free Cash Flows Ratio22.71
Price to Tangible Book Ratio4.93
Enterprise Value to Sales2.18
Enterprise Value Over EBITDA12.11
EV to Operating Cash Flow20.25
Earnings Yield4.46%
Free Cash Flow Yield4.87%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of GE HealthCare Technologies Inc. (GEHC) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 24.029 in 2024.

What is the ticker symbol of GE HealthCare Technologies Inc. stock?

The ticker symbol of GE HealthCare Technologies Inc. stock is GEHC.

What is company IPO date?

IPO date of GE HealthCare Technologies Inc. is 2022-12-15.

What is company current share price?

Current share price is 82.730 USD.

What is stock market cap today?

The market cap of stock today is 37763379233.000.

What is PEG ratio in 2024?

The current 0.682 is 0.682 in 2024.

What is the number of employees in 2024?

In 2024 the company has 51000.